<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: fluid retention</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Common pregnancy conditions risk future diabetes</title>
   	 <description>Two common conditions in pregnancy may be risk factors for future diabetes according to a Canadian study of over one million women published in this week's PLOS Medicine.</description>
     <link>http://medicalxpress.com/news/2013-04-common-pregnancy-conditions-future-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Tue, 16 Apr 2013 17:30:41 EST</pubDate>
	 <guid isPermaLink="false">news285352231</guid>
	 
</item>
<item>
     <title>Study examines global management of anemia in children on dialysis</title>
   	 <description>Children on dialysis who have anemia and who require high doses of drugs to treat it have an increased risk of dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings provide new insights that may help improve the health of children with kidney failure.</description>
     <link>http://medicalxpress.com/news/2013-03-global-anemia-children-dialysis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 07 Mar 2013 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news281894660</guid>
	 
</item>
<item>
     <title>FDA OKs expanded use of prostate cancer drug</title>
   	 <description>(HealthDay)—The approved use of the drug Zytiga has been expanded to include treatment of men with late-stage, hormone therapy-resistant  prostate cancer before they undergo chemotherapy, the U.S. Food and Drug Administration announced Monday.</description>
     <link>http://medicalxpress.com/news/2012-12-fda-oks-prostate-cancer-drug.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 10 Dec 2012 17:20:04 EST</pubDate>
	 <guid isPermaLink="false">news274379071</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/fdaoksexpand.jpg" width="90" height="90" />
</item>
<item>
     <title>Genetics point to serious pregnancy complication</title>
   	 <description>New research at the University of Adelaide has revealed a genetic link in pregnant mums - and their male partners - to pre-eclampsia, a life-threatening complication during pregnancy.</description>
     <link>http://medicalxpress.com/news/2012-11-genetics-pregnancy-complication.html</link>
	 <category>Obstetrics &amp; gynaecology</category>
	 <pubDate>Thu, 15 Nov 2012 10:47:57 EST</pubDate>
	 <guid isPermaLink="false">news272198869</guid>
	 
</item>
<item>
     <title>Thiazolidinedione use in patients with Type 2 diabetes may increase risk for diabetic macular edema</title>
   	 <description>Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year follow-up evaluations, according to a report published Online First by Archives of Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2012-06-thiazolidinedione-patients-diabetes-diabetic-macular.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 11 Jun 2012 16:01:45 EST</pubDate>
	 <guid isPermaLink="false">news258649293</guid>
	 
</item>
<item>
     <title>Clinical trial examines benefits of, mechanisms behind ultrafiltration for heart failure</title>
   	 <description>University of Cincinnati cardiologists are conducting a one-of-a-kind clinical trial to determine if a dialysis-like procedure could be deemed the new standard of care for patients suffering from extensive fluid retention caused by heart failure.</description>
     <link>http://medicalxpress.com/news/2012-02-clinical-trial-benefits-mechanisms-ultrafiltration.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 23 Feb 2012 07:43:27 EST</pubDate>
	 <guid isPermaLink="false">news249205376</guid>
	 
</item>
<item>
     <title>Popular diabetes drugs' cardiovascular side effects explained</title>
   	 <description>Drugs known as thiazolidinediones, or TZDs for short, are widely used in diabetes treatment, but they come with a downside. The drugs have effects on the kidneys that lead to fluid retention as the volume of plasma in the bloodstream expands.</description>
     <link>http://medicalxpress.com/news/2011-05-popular-diabetes-drugs-cardiovascular-side_1.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 03 May 2011 12:17:37 EST</pubDate>
	 <guid isPermaLink="false">news223643824</guid>
	 
</item>


</channel>
</rss>
